Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07765134

Comprehensive Kidney Function Assessment and Early Warning in Older Adults

Conditions: Kidney Function Decline, Chronic Kidney Disease, Kidney Failure

Sex: All
Ages: 60 Years – N/A
Healthy volunteers: Yes
Enrollment: 5588
Sponsor: Huashan Hospital

Location: Huashan Hospital, Fudan University Shanghai Shanghai Municipality

Summary

This completed observational cohort study evaluates a comprehensive set of clinical and molecular markers of kidney function in two established cohorts of Chinese adults aged 60 years or older. The study assesses markers reflecting glomerular filtration, kidney tubular transport, and kidney endocrine function and evaluates their associations with kidney failure, cardiovascular and cerebrovascular events, and all-cause mortality. It also compares approaches to estimating glomerular filtration rate and develops and internally validates an early-warning model for kidney function decline. Existing baseline and follow-up data and stored serum and urine specimens are used. No intervention or additional study-specific clinical procedure is administered.

Eligibility Criteria

Inclusion Criteria: 1. Enrollment in the Rugao Longevity and Ageing Study or the Shanghai Older-Adult Cohort. 2. Age 60 years or older, of either sex, with a baseline estimated glomerular filtration rate greater than 60 mL/min/1.73 m². 3. Availability of the baseline data required for the study, including blood pressure, body weight, body mass index, smoking and alcohol use, surgical history, family history, complete blood count, liver function, electrolytes, kidney function, serum cystatin C, blood glucose, urinalysis, and urinary albumin-to-creatinine ratio. 4. Availability of follow-up information sufficient to ascertain the prespecified clinical outcomes. 5. Clinically stable condition and adequate ability to understand and communicate at enrollment in the parent cohort. 6. Written informed consent for participation and the permitted research use of clinical data and stored biospecimens. Exclusion Criteria: 1. Missing essential baseline or follow-up data required for the relevant analysis. 2. Unavailability of stored blood or urine specimens required for the planned biomarker analysis. 3. Missing information on lifestyle, health-related behaviors, or social support required for the relevant analysis.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07765134). StuddyBuddy aggregates publicly available trial information.